Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000144.xml
Zeitschrift für Orthomolekulare Medizin 2016; 1(01): 3-9
DOI: 10.1055/s-0035-1547596
DOI: 10.1055/s-0035-1547596
Wissen
Alzheimer – eine vermeidbare Umwelterkrankung
Further Information
Publication History
Publication Date:
20 April 2016 (online)
![](https://www.thieme-connect.de/media/OM/201601/lookinside/thumbnails/10-1055-s-0035-1547596-1.jpg)
Zusammenfassung
Die starke Zunahme von Alzheimer in den letzten Jahrzehnten verlief nicht parallel zur Altersentwicklung, sondern zur Veränderung externer Faktoren wie dem Konsum industriell verarbeiteter Lebensmittel und der Aufnahme neurotoxischer Substanzen. Die Ernährung kann je nach Zusammensetzung die Pathomechanismen von Alzheimer auslösen oder auch protektiv wirken, wie verschiedene Vitamine und Fettsäuren dies tun.
-
Literatur
- 1 Rorsman B, Hagnell O, Lanke J. Prevalence and incidence of senile and multi-infarct dementia in the Lundby Study: a comparison between the time periods 1947–1957 and 1957–1972. Neuropsychobiology 1986; 15: 122-129
- 2 Rocca WA, Cha RH, Waring SC, Kokmen E. Incidence of dementia and Alzheimer’s disease: a reanalysis of data from Rochester, Minnesota, 1975–1984. Am J Epidemiol 1998; 148: 51-62
- 3 Cornutiu G. The incidence and prevalence of Alzheimer’s disease. Neurodegener Dis 2011; 8(1–2): 9-14
- 4 Grant WB. Trends in diet and Alzheimer’s disease during the nutrition transition in Japan and developing countries. J Alzheimers Dis 2014; 38(3): 611-620
- 5 Srikanth V, Maczur ek, Phan T et al. Advanced glycation endproducts and their receptor RAGE in Alzheimer’s disease. Neurobiology of Aging 2011; 32(5): 763-777
- 6 Uribarri J, Woodruff S, Goodman S. Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet. J Am Diet Assoc 2010; 110(6): 911-16.e12
- 7 Perrone L. Observational and ecological studies of dietary advanced glycation end products in national diets and Alzheimer’s disease incidence and prevalence. J Alzheimers Dis 2015; 45(3): 965-979
- 8 Richardson J. Elevated Serum Pesticide Levels and Risk for Alzheimer Disease. JAMA Neurol 2014; 71(3): 284-290
- 9 Zhang W, Jiang F, Ou J. Global pesticide consumption and pollution: with China as a focus. Proceedings of the International Academy of Ecology and Environmental Sciences 2011; 125-144
- 10 Baldi I. Neurodegenerative Diseases and Exposure to Pesticides in the Elderly. Am J Epidemiol 2003; 157: 409-414
- 11 Yi SW. Agent Orange exposure and disease prevalence in Korean Vietnam veterans: the Korean veterans health study. Environ Res 2014; 133: 56-65
- 12 Klatzo I, Wisniewski H, Streicher E. Experimental production of neurofibrillary degeneration I. Light microscopic observation. Journal of Neuropathology & experimental Neurology 1965; 24: 187-199
- 13 Virk SA. Aluminum Levels in Brain, Serum, and Cerebrospinal Fluid are Higher in Alzheimer’s Disease Cases than in Controls: A Series of Meta-Analyses. J Alzheimers Dis 2015; 47(3): 629-638
- 14 Ehgartner B. Morbus Alzheimer: Nach Jahren Auftrieb für die Aluminiumhypothese. Dtsch Ärztebl 2013; 110(6): 222-
- 15 Rondeau V. Relation between Aluminum Concentrations in Drinking Water and Alzheimer’s Disease: An 8-year Follow-up Study. Am J Epidemiol 2000; 152: 59-66
- 16 Sayed S. Aluminium content of some foods and food products in the USA, with aluminium food additives. Food Additives and Contaminants 2005; 22(3): 234-244
- 17 Chen CW. Increased risk of dementia in people with previous exposure to general anesthesia: a nationwide population-based case-control study. Alzheimers Dement 2014; 10(2): 196-204
- 18 Kalmijn S, Feskens EJM, Launer LJ, Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 1997; 145: 33-41
- 19 Sasaki N et al. Advanced glycation end products in Alzheimer’s disease and other neurodegenerative diseases. Am J Pathol 1998; 153: 1149-
- 20 Lue LF. Receptor for advanced glycation end products: its role in Alzheimer’s disease and other neurological diseases. Future Neurol 2009; 4: 167-